Used to measure levels of MIP-3α/CCL20 in biological samples such as serum, plasma, or cell culture supernatants. This assay helps in studying inflammatory responses, immune cell recruitment, and disease mechanisms involving the CCL20-CCR6 axis. Commonly applied in research on autoimmune diseases, infectious diseases, cancer, and mucosal immunity. Supports quantification of protein expression changes in response to treatments or genetic modifications. Suitable for preclinical studies and biomarker discovery.